Letter: the potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa

被引：2
|
作者：
Maraolo, A. E. [1 ]
Minervini, F. [1 ]
Tosone, G. [1 ]
机构：
[1] Univ Naples Federico II Infect Dis, Dept Clin Med & Surg, Naples, Campania, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2015年 / 41卷 / 06期
关键词：
D O I：
10.1111/apt.13071
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [1] Long-term therapy of chronic delta hepatitis with peginterferon alfa
    Heller, T.
    Rotman, Y.
    Koh, C.
    Clark, S.
    Haynes-Williams, V.
    Chang, R.
    McBurney, R.
    Schmid, P.
    Albrecht, J.
    Kleiner, D. E.
    Ghany, M. G.
    Liang, T. J.
    Hoofnagle, J. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (01) : 93 - 104
  • [2] Subacute Thyroiditis During Peginterferon Alfa Therapy for Chronic Hepatitis Delta
    Kuzu, Fatih
    Akdemir, Elif Neslihan
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2018, 2 (03): : 182 - 185
  • [3] Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
    Keiichi Masaki
    Fumitaka Suzuki
    Tasuku Hara
    Yusuke Kawamura
    Hitomi Sezaki
    Tetsuya Hosaka
    Norio Akuta
    Masahiro Kobayashi
    Satoshi Saitoh
    Yoshiyuki Suzuki
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Hiromitsu Kumada
    Virology Journal, 12
  • [4] LONG-TERM EVALUATION OF NEUROCOGNITIVE PERFORMANCE IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION AND PEGINTERFERON-ALFA-BASED THERAPY
    Schaefer, Arne
    Teuber, Gerlinde
    Wollschlaeger, Sven
    Scheurlen, Michael
    Kraus, Michael R.
    HEPATOLOGY, 2010, 52 (04) : 792A - 793A
  • [5] Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
    Masaki, Keiichi
    Suzuki, Fumitaka
    Hara, Tasuku
    Kawamura, Yusuke
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Akuta, Norio
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    VIROLOGY JOURNAL, 2015, 12
  • [6] Virological and immunological predictors of long-term ouctomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B
    Lee, I-Cheng
    Su, Chien-Wei
    Lan, Keng-Hsin
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E471 - E471
  • [7] LONG-TERM, HIGH-DOSE PEGINTERFERON ALFA-2A IS AN EFFECTIVE TREATMENT FOR CHRONIC HEPATITIS D
    Heller, Theo
    Rotman, Yaron
    Haynes-Williams, Vanessa
    Kleiner, David E.
    Ghany, Marc G.
    Liang, T. Jake
    Hoofnagle, Jay H.
    HEPATOLOGY, 2009, 50 (04) : 734A - 734A
  • [8] Interferon alfa and/or lamivudine therapy in chronic delta hepatitis
    Akarca, US
    Ersöz, G
    Günsar, F
    Karasu, Z
    Cavusoglu, H
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2000, 32 : 199 - 199
  • [9] LONG-TERM THERAPY OF CHRONIC HEPATITIS AND OF HEPATOCIRRHOSIS
    PUSCH, HJ
    ULLMANN, W
    MEDIZINISCHE KLINIK, 1975, 70 (15) : 674 - 681
  • [10] Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
    Jung, Chang Ho
    Um, Soon Ho
    Kim, Tae Hyung
    Yim, Sun Young
    Suh, Sang Jun
    Yim, Hyung Joon
    Seo, Yeon Seok
    Choi, Hyuk Soon
    Chun, Hoon Jai
    GUT AND LIVER, 2016, 10 (05) : 808 - 817
12345